Kit For The Preparation Of Technetium Tc99m Mertiatide Injection, Powder, Lyophilized, For Solution
Product Images NDC 45567-0655

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Kit For The Preparation Of Technetium Tc99m Mertiatide (NDC 45567-0655). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Technetium 01)

Chemical structure diagram showing the molecular structure of betiatide and technetium Tc 99m mertiatide, the active ingredient in the Kit for the Preparation of Technetium Tc99m Mertiatide injection powder, lyophilized for intravenous use by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Mertiatide Carton Label (Technetium 02)

Packaging label for Kit for the Preparation of Technetium Tc99m Mertiatide 1 mg Betiatide vial, an injection powder, lyophilized for solution, for intravenous use. The label is green with black and white text, produced by Sun Pharmaceutical Industries, Inc. The label includes dosage form details, preparation and contents information, and customer service contact. Instructions mention use after reconstitution and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.